A Phase III Study of SYHX1901 Tablets in the Treatment of Moderate to Severe Plaque Psoriasis
Clinical trial NCT06943950 · NOT_YET_RECRUITING
Trial details
- NCT number
- NCT06943950
- Sponsor
- CSPC Ouyi Pharmaceutical Co., Ltd.
- Status
- NOT_YET_RECRUITING
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2025-06-01
- Primary completion
- 2027-04-28
- Enrollment
- 500
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.